Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
publishDate:"[2020 TO 2029]"
journalStr:"Annals of the rheumatic diseases"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2020+TO+2029%5D%22&filter%5B%5D=journalStr%3A%22Annals+of+the+rheumatic+diseases%22&lookfor=%22Immunosuppressive+Agents%22&type=Subject
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2020+TO+2029%5D%22&filter%5B%5D=journalStr%3A%22Annals+of+the+rheumatic+diseases%22&lookfor=%22Immunosuppressive+Agents%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=publishDate%3A%22%5B2020+TO+2029%5D%22&filter%5B%5D=journalStr%3A%22Annals+of+the+rheumatic+diseases%22&lookfor=%22Immunosuppressive+Agents%22&type=Subject
PubPharm (76)
1
Withdrawal of immunosuppressants and low-dose steroids in patients with stable IgG4-RD (WInS IgG4-RD) : an investigator-initiated, multicentre, open-label, randomised controlled trial
enthalten in:
Annals of the rheumatic diseases
| 2024
von
Peng, L.
|
Nie, Y.
|
Zhou, J.
| +12
Wird geladen...
2
Low plasma belimumab levels as an indicator of poor adherence to belimumab in patients with systemic lupus erythematosus
enthalten in:
Annals of the rheumatic diseases
| 2024
von
Trefond, L.
|
Zahr, N.
|
Lhote, R.
| +11
Wird geladen...
3
Pragmatic targets for moderate/severe SLE and their implications for clinical care and trial design : sustained DORIS or LLDAS for at least 6 months is sufficient while their attainment for at least 24 months ensures high specificity for damage-free progression
enthalten in:
Annals of the rheumatic diseases
| 2024
von
Pitsigavdaki, S.
|
Nikoloudaki, M.
|
Garantziotis, P.
| +12
Wird geladen...
4
Maintenance of remission of ANCA vasculitis by rituximab based on B cell repopulation versus serological flare : a randomised trial
enthalten in:
Annals of the rheumatic diseases
| 2024
von
Zonozi, R.
|
Cortazar, F.
|
Jeyabalan, A.
| +10
Wird geladen...
5
Rituximab as maintenance therapy for ANCA-associated vasculitides : pooled analysis and long-term outcome of 277 patients included in the MAINRITSAN trials
enthalten in:
Annals of the rheumatic diseases
| 2024
von
Delestre, F.
|
Charles, P.
|
Karras, A.
| +104
Wird geladen...
6
Efficacy and safety of avacopan in patients with ANCA-associated vasculitis receiving rituximab in a randomised trial
enthalten in:
Annals of the rheumatic diseases
| 2024
von
Geetha, D.
|
Dua, A.
|
Yue, H.
| +105
Wird geladen...
7
Reduced-dose versus high-dose glucocorticoids added to rituximab on remission induction in ANCA-associated vasculitis : predefined 2-year follow-up study
enthalten in:
Annals of the rheumatic diseases
| 2024
von
Furuta, S.
|
Nakagomi, D.
|
Kobayashi, Y.
| +17
Wird geladen...
8
EULAR recommendations for the management of systemic lupus erythematosus : 2023 update
enthalten in:
Annals of the rheumatic diseases
| 2024
von
Fanouriakis, A.
|
Kostopoulou, M.
|
Andersen, J.
| +39
Wird geladen...
9
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis : results from the observational GCAGE study on a large cohort of 1004 patients
enthalten in:
Annals of the rheumatic diseases
| 2023
von
Monti, S.
|
Milanesi, A.
|
Klersy, C.
| +46
Wird geladen...
10
Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes
enthalten in:
Annals of the rheumatic diseases
| 2023
von
Choi, M.
|
Chen, I.
|
Clarke, A.
| +38
Wird geladen...
1
2
3
4
5
6
7
8
Nächster »
[8]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Erscheinungsjahr: 2020-2029
Filter aufheben
Zeitschrift: Annals of the rheumatic diseases
Medienart
76
Aufsätze
76
E-Artikel
76
E-Ressourcen
Zeitschriftentitel
Annals of the rheumatic diseases
Thema
76
Immunosuppressive Agents
48
Journal Article
31
Research Support, Non-U.S. Gov't
28
Letter
20
Glucocorticoids
18
autoimmune diseases
16
Antibodies, Monoclonal, Humanized
16
Randomized Controlled Trial
14
Antirheumatic Agents
12
4F4X42SYQ6
12
Comment
12
Hydroxychloroquine
12
Rituximab
11
4QWG6N8QKH
11
8N3DW7272P
11
Cyclophosphamide
11
HU9DX48N0T
11
Mycophenolic Acid
11
belimumab
11
systemic vasculitis
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2020-
8
2024
13
2023
17
2022
15
2021
23
2020
Alle anzeigen ...
weniger ...
Erscheinungsjahr(e)
Von:
Bis:
Sprache
76
Englisch
Haven't found what you're looking for?
Wird geladen...